Searching for Blood DNA Methylation Markers of Breast Cancer Risk and Early Detection
A partir d'échantillons sanguins prélevés sur 298 femmes ayant développé un cancer du sein dans les cinq ans après leur inclusion dans la cohorte "Sister Study" et sur 612 témoins, cette étude identifie une signature qui, basée sur la méthylation de l'ADN sur des îlots CpG, est susceptible d'être utile au diagnostic et à l'estimation du risque d'un cancer du sein
In this issue of the Journal, Xu et al. used prospectively collected blood samples to determine whether epigenome-wide methylation profiles in blood DNA differ between women who subsequently develop breast cancer and those who do not. Potentially, such a profile could predict the risk of developing breast cancer or detect this disease days to several years before it appears clinically. Existing breast cancer risk prediction models have limited discriminatory accuracy for this common disease, and improved methods for early detection are also needed. In this context, the findings of Xu et al. are promising and exemplify the potential value of epigenome-wide association studies. However, several important considerations temper the initial enthusiasm and highlight challenges for future studies.
Journal of the National Cancer Institute , éditorial, 2013